ReviewThe utility of GLUT1 as a diagnostic marker in cutaneous vascular anomalies: A review of literature and recommendations for daily practice
Introduction
‘Vascular anomalies’ is an umbrella term used for lesions that stem from abnormalities in either blood vessels, lymphatic vessels, or both. Historically, the nomenclature for these vascular lesions has been vague and contradicting [1]. The first organized classification was published by Mulliken and Glowacki in 1982, distinguishing vascular tumors (lesions growing by endothelial hyperplasia, likehemangiomas) from vascular malformations (lesions with quiescent endothelium, considered localized defects of vascular morphogenesis) [2]. This basic classification system was adopted by the International Society for the Study of Vascular Anomalies (ISSVA) in 1993 [3]. Over the years, imaging techniques, immunohistochemistry and genetic studies have allowed for new diagnostic and classification opportunities in vascular anomalies, leading to various ISSVA classification updates [4], [5], [6]. Nonetheless, unambiguous classification of vascular anomalies remains a challenge. Wassef et al. published an introduction into the latest ISSVA classification update in 2015, striving for uniform classification of vascular anomalies by pathologists, clinicians, and researchers [6].
In 2000, North et al. found that the endothelial cells of infantile hemangiomas (IH) are immunoreactive for the Glucose Transporter Type 1 (GLUT1), contrary to the vascular endothelium in normal skin. They did not find comparable immunostaining in vascular malformations, rendering GLUT1 a potential marker for IH [7]. This led to new hypotheses regarding the origin of infantile hemangiomas, translating into the placental embolization theory of IH that still has supporters this day [8]. Although of undisputed scientific value, the clinical applicability of GLUT1 staining in infantile hemangiomas has not been addressed. Therefore, we aimed to define the utility of GLUT1 in the diagnostics of cutaneous vascular anomalies.
Section snippets
Materials and methods
The objective of this study was to assess the utility of GLUT1 staining in the diagnostics of cutaneous vascular anomalies. We searched PubMed for studies reporting on GLUT1 immunostaining patterns for different types of vascular anomalies (primary outcome). The search strategy was designed to entail all entities recognized by the latest ISSVA classification [Table 1] in combination with “GLUT1”. Exclusion criteria were: studies of non-cutaneous vascular anomalies; studies where GLUT1 was not
Results
Our search rendered 197 results. Title and abstract screening led to the exclusion 156 citations. Out of the 41 remaining citations, 21 relevant papers were included [Table 2]. The results of data extraction are discussed below. Findings are summarized in Table 3.
Discussion
In order to clarify the role of GLUT1 as a diagnostic tool in cutaneous vascular lesions, we reviewed published cases reporting on GLUT1 staining in vascular anomalies. Infantile hemangiomas were investigated most frequently, and nearly all tumors (95%) were positive for GLUT1. With this near ubiquitous GLUT1 immunoreactivity, it can be suspected that IH endothelium might inherently possess the Glucose Transporter Type 1. Similarly, North et al. argue that at least two out of four lesions that
Funding
None.
Conflicts of interest
None to declare.
References (40)
- et al.
GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas
Hum. Pathol.
(2000) - et al.
GLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations
Br. J. Plast. Surg.
(2005) - et al.
GLUT-1 expression in mesenchymal tumors: an immunohistochemical study of 247 soft tissue and bone neoplasms
Hum. Pathol.
(2008) - et al.
Infantile and congenital hemangiomas
Semin. Pediatr. Surg.
(2014) - et al.
Postcricoid vascular lesions: histopathological and immunohistochemical diagnosis
Laryngoscope
(2011) - et al.
Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics
Plast. Reconstr. Surg.
(1982) - et al.
Introduction: ISSVA Classification Excerpt from ‘Color Atlas of Vascular Tumors and Vascular Malformations’
(2017) - et al.
Vascular tumors and vascular malformations (new issues)
Adv. Dermatol.
(1997) - et al.
Update on the classification of hemangioma
J. Oral Maxillofac. Pathol.
(2014) - et al.
Vascular anomalies classification: recommendations from the International Society for the Study of Vascular Anomalies
Pediatrics
(2015)
Does hypoxia play a role in infantile hemangioma?
Arch. Dermatol. Res.
Congenital nonprogressive hemangioma: a distinct clinicopathologic entity unlike infantile hemangioma
Arch. Dermatol.
A unique microvascular phenotype shared by juvenile hemangiomas and human placenta
Arch. Dermatol.
Extracutaneous infantile haemangioma is also Glut1 positive
J. Clin. Pathol.
Usefulness of D2-40 immunohistochemistry for differentiation between kaposiform hemangioendothelioma and tufted angioma
J. Cutan. Pathol.
Wilms tumor 1 expression in vascular neoplasms and vascular malformations
Am. J. Dermatopathol.
Benign vascular proliferations–an immunohistochemical and comparative study
Pol. J. Pathol.
Visceral and mucosal involvement in neonatal haemangiomatosis
J. Eur. Acad. Dermatol. Venereol.
Dilated lymphatic vessels in tufted angioma: a potential source of diagnostic confusion
Am. J. Dermatopathol.
Clinicopathological features of Kaposiform hemangioendothelioma
Int. J. Clin. Exp. Pathol.
Cited by (38)
Medical Management of Nonmalignant Vascular Tumors of the Head and Neck: Part 1
2024, Oral and Maxillofacial Surgery Clinics of North AmericaVascular Malformations: A Histopathologic and Conceptual Appraisal
2023, Actas Dermo-SifiliograficasDigital subtraction angiography and trans arterial embolization in preventing massive hemorrhage of Kaposiform hemangioendothelioma: A case report
2022, Radiology Case ReportsCitation Excerpt :This may have been caused by sporadic somatic mutations which occurred due to vascular malformations. These findings show that the diagnosis of the disease cannot be based on one positive or negative finding on Immunohistochemistry examination [11]. Options for therapy in KHE are systemic or intralesional steroids, low dose radiotherapy, excisional surgery, and chemotherapy with vincristine, cyclophosphamide, and sirolimus.
Advances in Pediatric Periocular Vascular Neoplasms
2022, Advances in Ophthalmology and OptometryCitation Excerpt :They consist of intravenous lobular capillary hemangioma and have a tendency to bleed, and surgical curettage/excision is definitive (Fig. 2) [15]. Tufted angioma and Kaposiform hemangioendothelioma are considered to be part of a spectrum of the same disease and exhibit lymphatic antigens, while being negative for GLUT-1 [16]. These lesions involve extremities, and their presence in head and neck region is rare.
Infantile hemangioma. Part 1: Epidemiology, pathogenesis, clinical presentation and assessment
2021, Journal of the American Academy of DermatologyCitation Excerpt :Involuting IHs show a reduction in vessel number, with a flattened, less mitotically active endothelium and apoptotic debris in a more conspicuous fibrous and fatty stroma.85 GLUT-1 staining of the endothelium is a sensitive marker for IH, absent in most other vascular tumors and malformations (Fig 7).86 Investigations and recommendations about referral to other specialists are summarized in Table III.
Imaging of Vascular Anomalies in the Pediatric Musculoskeletal System
2021, Seminars in RoentgenologyCitation Excerpt :IHs are more common among girls (4:1) and premature infants, especially those with a birth weight <1500 g. These lesions are composed of tight clusters of plump capillary endothelium that almost always (approximately 95%) stain positive for glucose transporter-1 (GLUT-1).6,20 The majority of lesions involve the skin with a characteristic clinical appearance as a soft bright red papule, nodule or plaque raised above clinically normal skin, resulting in the classic “strawberry lesion.”